Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche presents compounds for HBV infection

May 28, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

Janssen Pharmaceutica discloses BACE1 and/or BACE2 inhibitors

May 28, 2018

Pfizer's Xeljanz approved for new indication in Japan

May 28, 2018

Janssen to terminate studies of daratumumab with atezolizumab and JNJ-63723283

May 28, 2018

Croma-Pharma identifies H2S-releasing compounds

May 28, 2018

Beactica extends master service agreement with Sanofi

May 28, 2018

Roche and Genentech disclose IRAK-4 inhibitors

May 28, 2018

Japanese approval for Opdivo with Yervoy in unresectable melanoma

May 28, 2018

Oncolytics Biotech and the Keck School of Medicine collaborate to study new Reolysin combination

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...